Virtus Investment Advisers’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$388K Buy
39,660
+13,340
+51% +$132K 0.09% 294
2026
Q1
$256K Buy
26,320
+641
+2% +$5.87K 0.07% 311
2025
Q4
$245K Buy
25,679
+3,236
+14% +$32.9K 0.07% 337
2025
Q3
$219K Buy
22,443
+3,896
+21% +$29.9K 0.06% 252
2025
Q2
$113K Buy
18,547
+6,656
+56% +$50K 0.04% 324
2025
Q1
$147K Buy
+11,891
New +$168K 0.04% 340

Other funds holding PRTA

Virtus Investment Advisers's PRTA Position: Q2 2026 in Review

Virtus Investment Advisers increased its Prothena Corp (PRTA) stake by 51% in Q2 2026, buying an estimated $132K and bringing the position to 39,660 shares worth $388K. The position accounts for 0.09% of the portfolio, ranked #294.

Virtus Investment Advisers first reported a position in PRTA in Q1 2025 and has held it in 6 quarters since. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Virtus Investment Advisers held 39,660 shares of Prothena Corp worth $388K as of Q2 2026.
  • Virtus Investment Advisers bought 13,340 Prothena Corp shares in Q2 2026, an estimated $132K.
  • Prothena Corp made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #294 holding.
  • Virtus Investment Advisers first reported a position in Prothena Corp in Q1 2025 and has held it in 6 quarters since.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.